|

Lenvatinib 10 mg Clinical Trials

1 actively recruiting trial

Also known as: Lenvima®

Pipeline

Early 1: 1

Top Sponsors

  • Chang Gung Memorial Hospital1

Indications

  • Liver Disease1
  • High Risk of Recurrence1
  • Liver Cancer1
  • Cancer1

Other1 trial

Innovative Diagnosis and Therapy in LDLT Patients With High-risk Hepatocellular Carcinoma
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.